Omeros competitors

Omeros Competitors include ACADIA Pharmaceuticals, Akorn, Catalyst Pharmaceuticals and Acticor Biotech.
Add company...
Omeros
Omeros
Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
Akorn
Akorn
Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
Acticor Biotech
Acticor Biotech
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
Founding Date
Founding Date
1994
Founding Date
1993
Founding Date
1948
Founding Date
2002
Founding Date
2013
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Seattle, US HQ
Locations
San Diego, US HQ
Locations
Lake Forest, US HQ
Gurugram, IN
Jersey, JE
Brooklyn, US
Houston, US
Queens, US
Ann Arbor, US
Locations
Coral Gables, US HQ
Locations
Paris, FR HQ
Employees
Employees
17312% increase
Employees
42515% increase
Employees
2,2841% increase
Employees
2117% increase
Employees
913% increase
Valuation ($)
Valuation ($)
703.3 m
Valuation ($)
2.3 b
Valuation ($)
543.4 m
Valuation ($)
246.6 m
Valuation ($)
N/A
Twitter followers
Twitter followers
80
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
436
Twitter followers
241

Financial

Revenue (est.)
Revenue (est.)
$64.8m (FY, 2017)
Revenue (est.)
$124.9m (FY, 2017)
Revenue (est.)
$841m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$1.1m (FY, 2017)
Cost of goods
$9.1m (FY, 2017)
Cost of goods
$407.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$63.7m (FY, 2017)
Gross profit
$115.8m (FY, 2017)
Gross profit
$433.1m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($53.5m) (FY, 2017)
Net income
($289.4m) (FY, 2017)
Net income
($24.6m) (FY, 2017)
Net income
($18.4m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 354.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 25.6m
For sources of this data, please see the company profileDownload Excel

View company profiles

ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
425↑ 15% increase

ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

View company
Akorn
HQ
Lake Forest, US
Employees
2,284↑ 1% increase

Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.

View company
Catalyst Pharmaceuticals
HQ
Coral Gables, US
Employees
21↑ 17% increase

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.

View company
Acticor Biotech
HQ
Paris, FR
Employees
9↑ 13% increase

Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.

View company